Search Tag: liver cancer therapy

2025 12 Aug

  Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with cases projected to rise to 1.4 million annually by 2040. Many patients are diagnosed at advanced stages, requiring systemic therapies such as sorafenib, lenvatinib, atezolizumab–bevacizumab and tremelimumab–durvalumab. While these treatments can extend...Read more